Trump Administration Announces IVF Drug Discounts—What It Means for TFI Patients
Fertility Policy Update: Lower IVF Costs on the Horizon
On October 16, 2025, President Donald Trump introduced a plan to reduce IVF costs and expand access to fertility care. The initiative includes:
-
Discounted IVF Medications: A new platform, TrumpRX, will offer reduced prices on Gonal-f, Ovidrel, and Cetrotide starting in early 2026.
-
Employer Benefit Expansion: Employers will be encouraged to offer standalone infertility benefits, though no federal funding will be provided.
-
FDA Fast-Tracking: Pergoveris will be reviewed on a priority basis to accelerate its availability.
How This Affects TFI Patients
-
Planning IVF? You may see lower medication costs in 2026. TFI’s care team can help you understand how this impacts your cycle.
-
Already in Treatment? Your current plan remains unchanged. TFI will help you evaluate future options when discounts become available.
-
Employer Coverage? More companies may begin offering fertility benefits. TFI can assist in reviewing your insurance.
-
For Everyone: These changes could make IVF more accessible. TFI will continue to provide updates and guidance.
Key Takeaways
-
The TrumpRX program is not yet active—it’s expected to launch in early 2026.
-
Discounts apply only to select EMD Serono medications.
-
TFI remains committed to supporting patients with clear, timely information.
Your Fertility Journey Shouldn’t Wait
Policy changes take time—and may offer only limited benefits in the near term. For many patients, waiting could mean missing their best opportunity to build a family.
TFI is here to guide you with expert care and timely support. Schedule a consultation with our team today to explore your options.
For more details, see: Reuters — White House set to announce proposal seeking to make IVF more accessible or visit The Prelude Network® website.